Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Niranjan Meher"'
Autor:
Robin Peter, Anil P. Bidkar, Kondapa Naidu Bobba, Luann Zerefa, Chandrashekhar Dasari, Niranjan Meher, Anju Wadhwa, Adam Oskowitz, Bin Liu, Brian W. Miller, Kai Vetter, Robert R. Flavell, Youngho Seo
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Radiopharmaceutical therapy using $$\upalpha$$ α -emitting $$^{225}$$ 225 Ac is an emerging treatment for patients with advanced metastatic cancers. Measurement of the spatial dose distribution in organs and tumors is needed to inform treat
Externí odkaz:
https://doaj.org/article/e1d2c9d4e31443c086a6151ba318828e
Autor:
Jinkyu Jung, Eric L. Schneider, Wei Zhang, Hua Song, Meili Zhang, William Chou, Niranjan Meher, Henry F. VanBrocklin, Mary Helen Barcellos-Hoff, Tomoko Ozawa, Mark R. Gilbert, Daniel V. Santi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Central nervous system tumors have resisted effective chemotherapy because most therapeutics do not penetrate the blood-tumor-brain-barrier. Nanomedicines between ~ 10 and 100 nm accumulate in many solid tumors by the enhanced permeability a
Externí odkaz:
https://doaj.org/article/3d5e6d583d9c4105b0310e06048dd4f3
Publikováno v:
Pharmaceuticals, Vol 16, Iss 2, p 315 (2023)
Targeted nanotheranostic systems offer significant benefits due to the integration of diagnostic and therapeutic functionality, promoting personalized medicine. In recent years, prostate-specific membrane antigen (PSMA) has emerged as an ideal theran
Externí odkaz:
https://doaj.org/article/0cdb9960c299463c8162ef608b56cbb5
Autor:
Niranjan Meher, Gary W. Ashley, Anil P. Bidkar, Suchi Dhrona, Cyril Fong, Shaun D. Fontaine, Denis R. Beckford Vera, David M. Wilson, Youngho Seo, Daniel V. Santi, Henry F. VanBrocklin, Robert R. Flavell
Publikováno v:
ACS applied materials & interfaces, vol 14, iss 45
Tumoral uptake of large-size nanoparticles is mediated by the enhanced permeability and retention (EPR) effect, with variable accumulation and heterogenous tumor tissue penetration depending on the tumor phenotype. The performance of nanocarriers via
Autor:
Robert R. Flavell, Bin Liu, Jonathan Chou, Youngho Seo, Henry F. VanBrocklin, Rahul Aggarwal, David M. Wilson, Jiang He, Li Zhang, Ryan Tang, Yang Su, Denis Beckford-Vera, Chandrashekhar Dasari, Suchi Dhrona, Anju Wadhwa, Niranjan Meher, Umama Ali, Robin Peter, Emily A. Egusa, Scott Bidlingmaier, Emily Chan, Kondapa Naidu Bobba, Sinan Wang, Anil P. Bidkar
Figure S11: Antitumor activity of [225Ac]DOTA-YS5 in subcutaneous DU145 tumors in nude mice. Tumor volume, survival analysis, and weight measurements after the injections of [225Ac]DOTA-YS5 in DU145 xenografts (n=6).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088b646bab868db70b2465e494a23059
https://doi.org/10.1158/1078-0432.22820111.v1
https://doi.org/10.1158/1078-0432.22820111.v1
Autor:
Robert R. Flavell, Bin Liu, Jonathan Chou, Youngho Seo, Henry F. VanBrocklin, Rahul Aggarwal, David M. Wilson, Jiang He, Li Zhang, Ryan Tang, Yang Su, Denis Beckford-Vera, Chandrashekhar Dasari, Suchi Dhrona, Anju Wadhwa, Niranjan Meher, Umama Ali, Robin Peter, Emily A. Egusa, Scott Bidlingmaier, Emily Chan, Kondapa Naidu Bobba, Sinan Wang, Anil P. Bidkar
Supplementary Data: Methods and tables.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f7289143db436296a7edc67a5ed9fa
https://doi.org/10.1158/1078-0432.22820081
https://doi.org/10.1158/1078-0432.22820081
Autor:
Robert R. Flavell, Bin Liu, Jonathan Chou, Youngho Seo, Henry F. VanBrocklin, Rahul Aggarwal, David M. Wilson, Jiang He, Li Zhang, Ryan Tang, Yang Su, Denis Beckford-Vera, Chandrashekhar Dasari, Suchi Dhrona, Anju Wadhwa, Niranjan Meher, Umama Ali, Robin Peter, Emily A. Egusa, Scott Bidlingmaier, Emily Chan, Kondapa Naidu Bobba, Sinan Wang, Anil P. Bidkar
Purpose:Radiopharmaceutical therapy is changing the standard of care in prostate cancer and other malignancies. We previously reported high CD46 expression in prostate cancer and developed an antibody–drug conjugate and immunoPET agent based on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74df276bd1b0f4a10ef3859820857e8a
https://doi.org/10.1158/1078-0432.c.6571946.v1
https://doi.org/10.1158/1078-0432.c.6571946.v1
Publikováno v:
Handbook of Aggregation‐Induced Emission. :559-586
Publikováno v:
Handbook of Aggregation‐Induced Emission. :491-509
Publikováno v:
Materials Advances. 3:5980-5986
A unique fluorometric and colorimetric “light-up” sensing strategy has been conceptualized to detect chloroform and distinguish various volatile chlorinated solvents (VCSs) along with “dual-phase” security ink application.